Related Experiment Video
Updated: Aug 12, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: November 1, 2010
Absolute CD4+ T-lymphocyte and CD34+ stem cell counts by single-platform flow cytometry: the way forward
D Barnett1, V Granger, L Whitby
1UK NEQAS for Leucocyte Immunophenotyping, Department of Haematology, Royal Hallamshire Hospital, Sheffield. d.barnett@sheffield.ac.uk
Single-platform technology offers improved accuracy for enumerating CD4+ T lymphocytes and CD34+ stem cells. This method demonstrates lower inter-laboratory coefficients of variation (CVs) compared to dual-platform methods, enhancing quality control in clinical trials.
Area of Science:
- Immunophenotyping
- Flow Cytometry
- Cell Enumeration
Background:
- Accurate enumeration of CD4+ T lymphocytes and CD34+ stem cells is critical for clinical trials and patient management.
- Current methods involve dual-platform technology, which can exhibit significant inter-laboratory variability.
- The UK NEQAS for Leucocyte Immunophenotyping provides a benchmark for assessing laboratory performance.
Purpose of the Study:
- To evaluate the performance advantage of single-platform technology over dual-platform methods for cell enumeration.
- To compare the inter-laboratory variability of different single-platform approaches.
- To determine if single-platform technology improves quality control for CD4+ T lymphocyte and CD34+ stem cell counts.
Main Methods:
- Analysis of data from UK NEQAS for Leucocyte Immunophenotyping schemes.
- Comparison of inter-laboratory coefficients of variation (CVs) for CD4+ T lymphocyte and CD34+ stem cell counts obtained by single-platform and dual-platform methodologies.
- Subgroup analysis of different single-platform techniques (FlowCount, TruCount, volumetric).
Main Results:
- Single-platform technology consistently yielded lower inter-laboratory CVs for CD4+ T lymphocyte counts (mean 13.7%) compared to dual-platform methods (mean 23.4%).
- Among single-platform approaches, the volumetric method showed the lowest mean CV (7.1%), followed by TruCount (13%) and FlowCount (17.2%).
- Single-platform methods for CD34+ stem cell enumeration also demonstrated lower inter-laboratory CVs (mean 18.6%) than dual-platform technology (mean 28.6%).
Conclusions:
- Single-platform technology is advantageous for the absolute enumeration of CD4+ T lymphocytes and CD34+ stem cells.
- Adoption of single-platform technology is recommended to enhance the quality control of multi-centre clinical trial data.
- Standardized single-platform approaches can significantly reduce variability in cell subset enumeration.
More Related Videos
07:39Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper (cTfh) Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry
Published on: January 7, 2019
10:25Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019